Andrew E. Chapman

3.0k total citations · 1 hit paper
63 papers, 2.0k citations indexed

About

Andrew E. Chapman is a scholar working on Geriatrics and Gerontology, Oncology and Physiology. According to data from OpenAlex, Andrew E. Chapman has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Geriatrics and Gerontology, 19 papers in Oncology and 14 papers in Physiology. Recurrent topics in Andrew E. Chapman's work include Frailty in Older Adults (21 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Nutrition and Health in Aging (12 papers). Andrew E. Chapman is often cited by papers focused on Frailty in Older Adults (21 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers) and Nutrition and Health in Aging (12 papers). Andrew E. Chapman collaborates with scholars based in United States, Australia and Canada. Andrew E. Chapman's co-authors include Kristine Swartz, Ginah Nightingale, Supriya G. Mohile, Arti Hurria, Harvey Jay Cohen, Emily Hajjar, Heidi D. Klepin, Ajeet Gajra, Vani Katheria and William P. Tew and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Andrew E. Chapman

59 papers receiving 2.0k citations

Hit Papers

Validation of a Prediction Tool for Chemotherapy Toxicity... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew E. Chapman United States 20 831 623 586 505 400 63 2.0k
Marie Laurent France 19 614 0.7× 314 0.5× 172 0.3× 478 0.9× 324 0.8× 73 1.3k
H. Allemand France 28 116 0.1× 241 0.4× 355 0.6× 85 0.2× 131 0.3× 88 2.1k
Holly K. Van Houten United States 25 73 0.1× 105 0.2× 611 1.0× 205 0.4× 138 0.3× 75 2.4k
Stephen M. Sozio United States 30 175 0.2× 111 0.2× 539 0.9× 225 0.4× 852 2.1× 95 3.0k
Joyce Lii United States 21 253 0.3× 148 0.2× 260 0.4× 60 0.1× 90 0.2× 54 1.6k
Pawana Sharma United Kingdom 19 59 0.1× 114 0.2× 295 0.5× 213 0.4× 168 0.4× 34 1.6k
Vincent J. Willey United States 23 124 0.1× 80 0.1× 552 0.9× 111 0.2× 137 0.3× 91 1.8k
Christian Günster Germany 25 94 0.1× 307 0.5× 709 1.2× 41 0.1× 245 0.6× 121 1.9k
Greg D. Sacks United States 21 55 0.1× 240 0.4× 536 0.9× 39 0.1× 184 0.5× 70 1.4k
Kim Bouillon France 17 572 0.7× 70 0.1× 116 0.2× 468 0.9× 97 0.2× 21 1.4k

Countries citing papers authored by Andrew E. Chapman

Since Specialization
Citations

This map shows the geographic impact of Andrew E. Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Chapman more than expected).

Fields of papers citing papers by Andrew E. Chapman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew E. Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Chapman. The network helps show where Andrew E. Chapman may publish in the future.

Co-authorship network of co-authors of Andrew E. Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew E. Chapman. A scholar is included among the top collaborators of Andrew E. Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew E. Chapman. Andrew E. Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swartz, Kristine, et al.. (2025). Evaluation of the Distress Thermometer in older patients with cancer. Journal of Geriatric Oncology. 16(4). 102221–102221.
2.
Sedrak, Mina S., Can‐Lan Sun, Rachel A. Freedman, et al.. (2024). Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study. Journal of Cancer Survivorship. 18(4). 1131–1143. 5 indexed citations
4.
Swartz, Kristine, et al.. (2023). The association of the G8 questionnaire with treatment side effects and unscheduled care among older adults with breast cancer: A retrospective cohort study. Journal of Geriatric Oncology. 14(7). 101566–101566. 2 indexed citations
5.
Swartz, Kristine, Andrew E. Chapman, Tingting Zhan, & Kuang‐Yi Wen. (2023). Process evaluation of a G8 screening tool implementation in an outpatient oncology center. Journal of Geriatric Oncology. 15(1). 101605–101605. 1 indexed citations
6.
Swartz, Kristine, et al.. (2023). Risk factors for falls and fear of falling among older patients with cancer.. Journal of Clinical Oncology. 41(16_suppl). e24032–e24032.
7.
Li, Daneng, Can‐Lan Sun, Rebecca Allen, et al.. (2022). Risk Factors for Hospitalizations Among Older Adults with Gastrointestinal Cancers. The Oncologist. 27(1). e37–e44. 3 indexed citations
8.
Dotan, Efrat, William P. Tew, Supriya G. Mohile, et al.. (2020). Associations between nutritional factors and chemotherapy toxicity in older adults with solid tumors. Cancer. 126(8). 1708–1716. 23 indexed citations
9.
Lu‐Yao, Grace L., Ginah Nightingale, Nikita Nikita, et al.. (2020). Relationship between polypharmacy and inpatient hospitalization among older adults with cancer treated with intravenous chemotherapy. Journal of Geriatric Oncology. 11(4). 579–585. 27 indexed citations
10.
Roden, Dylan F., Richard A. Goldman, Jennifer M. Johnson, et al.. (2019). Evaluation of oncologic outcomes in head and neck cancer patients ≥80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment. Head & Neck. 41(12). 4128–4135. 11 indexed citations
11.
Jayani, Reena, Allison Magnuson, Can‐Lan Sun, et al.. (2019). Association between a cognitive screening test and severe chemotherapy toxicity in older adults with cancer. Journal of Geriatric Oncology. 11(2). 284–289. 14 indexed citations
12.
Ramsdale, Erika, et al.. (2017). Improving Quality and Value of Cancer Care for Older Adults. American Society of Clinical Oncology Educational Book. 383–393. 2 indexed citations
13.
Powell, Rhea E., et al.. (2017). Patient-Centered Specialty Practice. CHEST Journal. 151(4). 930–935. 15 indexed citations
14.
Hurria, Arti, Supriya G. Mohile, Ajeet Gajra, et al.. (2016). Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer. Journal of Clinical Oncology. 34(20). 2366–2371. 402 indexed citations breakdown →
15.
Magnuson, Allison, Heather Allore, Harvey Jay Cohen, et al.. (2016). Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research. Journal of Geriatric Oncology. 7(4). 242–248. 80 indexed citations
17.
Gajra, Ajeet, Heidi D. Klepin, Feng Tao, et al.. (2015). Predictors of chemotherapy dose reduction at first cycle in patients age 65years and older with solid tumors. Journal of Geriatric Oncology. 6(2). 133–140. 42 indexed citations
18.
Maggiore, Ronald J., William Dale, Mary K. Buss, et al.. (2014). Survey of geriatric oncology (geri onc) training among hematology/oncology (hem/onc) fellows.. Journal of Clinical Oncology. 32(15_suppl). e20519–e20519. 3 indexed citations
19.
Werner‐Wasik, Maria, et al.. (2002). Phase II: Trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy. Seminars in Radiation Oncology. 12(1). 34–39. 19 indexed citations
20.
Cooter, Rodney D., Wendy Babidge, Keith L. Mutimer, et al.. (2001). Ultrasound‐assisted lipoplasty. ANZ Journal of Surgery. 71(5). 309–317. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026